FDA Completes Review of Cibus Inc.'s Altered Lignin Alfalfa, Paving Way for U.S. Commercialization in Livestock Feed
Cibus Inc. and S&W Seed Company have completed the FDA’s Plant Biotechnology Consultation for their altered lignin alfalfa, enabling its commercialization in the U.S. This alfalfa variant enhances livestock digestibility and offers farmers greater harvest flexibility. The FDA's approval confirms its suitability for food and feed applications, highlighting Cibus's commitment to advancing beneficial agricultural traits.
Cibus Inc., in collaboration with S&W Seed Company, has announced the successful completion of the U.S. Food and Drug Administration’s Plant Biotechnology Consultation Program for their altered lignin alfalfa. This regulatory milestone allows for the U.S. commercialization of the alfalfa variant, which offers improved digestibility for livestock and increased harvest flexibility for farmers. The FDA’s approval confirms that the altered lignin alfalfa is suitable for food and feed applications. This development underscores Cibus’s commitment to advancing agricultural traits that benefit both farmers and the broader value chain. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cibus Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9483105-en) on June 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
